Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9567402
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted patentUS 9565840
Fibrotic non-human animal, and use thereof
granted patentUS 9561256
LLP2A-bisphosphonate conjugates for osteoporosis treatment
granted patentUS 9556131
Compositions, methods of use, and methods of treatment
granted patentUS 9555159
Inorganically surface-modified polymers and methods for making and using them
granted patentUS 9555114
Methods for in vivo drug delivery with porous nanostructures
granted patentUS 9555100
Herpes virus vaccine and methods of use
granted patentUS 9555073
Use of vitelline protein B as a microencapsulating additive
granted patentUS 9551722
Amyloid binding agents
granted patentUS 9550827
Methods for ameliorating and preventing central nervous system inflammation
granted patentUS 9549954
Method and composition for inducing human pluripotent stem cells
granted patentUS 9549905
Treatment of inflammatory and infectious skin disorders
granted patentUS 9546193
Compositions and methods for 18F-fluorodeoxyglycosylamines
granted patentUS 9545422
Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to
granted patentUS 9545461
Anti-microbial peptides and methods of use thereof
granted patentUS 9539340
Bladder cancer specific ligand peptides
granted patentUS 9539321
HMGB1-derived peptides enhance immune response to antigens
granted patentUS 9539300
Modulating disease through genetic engineering of plants
granted patentUS 9535076
Methods and compositions for eliciting an amyloid-selective immune response
granted patentUS 9534033
Targeted interferons demonstrating potent apoptotic and anti-tumor activities
granted patentUS 9532994
Agents and methods for enhancing bone formation by oxysterols in combination with bone mor
granted patentUS 9529001
Methods of diagnosing and treating autism
granted patentUS 9528994
Target of the phosphoinositide 3-kinase pathway
granted patentUS 9527919
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and d
granted